Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.09 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.09 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.09 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.089 | 0.09 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |